Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ICLR
#784
ICON plc - Ordinary Shares
164.6
6
USD
-0.03%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.15%
Monthly Change
-0.39%
6 month change
+55.62%
Year Change
-6.79%
Previous Close
170.0
2
Open
163.9
0
Low
163.5
7
High
165.1
4
Volume
148
Markets
US Stock Market
Healthcare
Diagnostics & Research
ICLR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
Q4, 25
Current
Key stats
Total common shares outstanding
76.57 M
76.57 M
Valuation ratios
Enterprise value
16.71 B
15.23 B
Price to earnings ratio
62.83
58.55
Price to sales ratio
—
—
Price to cash flow ratio
13.89
12.94
Price to book ratio
1.57
1.46
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
-0.05
-0.05
Return on equity %
-0.08
-0.08
Return on invested capital %
-19.54
-19.54
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
1.1
1.1
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
0.18
0.18
Debt to equity ratio
0.31
0.31
Long term debt to total assets ratio
0.21
0.21
Long term debt to total equity ratio
0.37
0.37
Per share metrics
Operating cash flow per share
-0.11
13.12
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
43.09
36.38
Cash per share
9.2
9.2
Net current asset value per share
44.34
44.34
Tangible book value per share
116.42
116.42
Working capital per share
3.87
3.87
Book value per share
116.42
116.42
News
Icon PLC (ICLR) Up 2.5% Since Last Earnings Report: Can It Continue?
Tracking Ruane, Cunniff, & Goldfarb’s Portfolio – Q2 2026 Update (MUTF:SEQUX)
Binance will delist ICX, SCRT, STORJ on September 3
Binance will add monitoring tags for GLMR, ICX, MOVR, RARE, and SOPH
Is ICON a Buy as Valuation Improves but Earnings Risks Still Persist?
Is MEDP Worth Buying as Growth Collides With a Premium Valuation?
ICLR Jumps 33.2% in Three Months as Recovery Expectations Strengthen
Can MEDP's Record Q2 Bookings Build a Stronger Growth Path for 2027?
Is IQVIA Stock a Buy as Growth Improves but High Leverage Persists?
Why IQVIA Stock Jumped 13% in a Week and Whether the Gains Can Last
Icon PLC (ICLR) Lags Q2 Earnings Estimates
Icon PLC (ICLR) Up 5.8% Since Last Earnings Report: Can It Continue?